Preclinical efficacy of multi-targeting mRNA-based CAR T cell therapy in resection models of glioblastoma
Traditional viral-based chimeric antigen receptor (CAR) T cell therapies have vanquished multiple blood malignancies with decade-long remissions yet struggle against solid tumors. Nonviral engineering of CAR T cells via electroporation or lipid nanoparticle (LNP) delivery of CAR-encoding mRNA result...
Saved in:
| Main Authors: | Oula K. Dagher, Martin Pedard, Darel Martinez Bedoya, Shawna K. Brookens, Denis Migliorini, Avery D. Posey, Jr. |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | Molecular Therapy: Nucleic Acids |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253125002306 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TYRP1 directed CAR T cells control tumor progression in preclinical melanoma models
by: Christopher S. Hackett, et al.
Published: (2024-09-01) -
Efficacy of MET-targeting CAR T cells against glioblastoma patient-derived xenograft models
by: Anna Qin, et al.
Published: (2025-04-01) -
Bortezomib promotes the TRAIL-mediated killing of resistant rhabdomyosarcoma by ErbB2/Her2-targeted CAR-NK-92 cells via DR5 upregulation
by: Catrin Heim, et al.
Published: (2024-06-01) -
Nonsignaling extracellular spacer regulates tumor antigen selectivity of CAR T cells
by: Kelly T. Kennewick, et al.
Published: (2024-06-01) -
Biomimetic extracellular vesicles derived from chimeric antigen receptor monocytes to treat glioblastoma: An efficient and safe intranasal drug delivery nanoplatform
by: Qihong Cheng, et al.
Published: (2025-10-01)